Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograft

SP Govek, JY Nagasawa, KL Douglas, AG Lai…

Index: WO2013/142266 A1, ;

Full Text: HTML

Citation Number: 2

Abstract

Selective estrogen receptor degraders (SERDs) have shown promise for the treatment of ER+ breast cancer. Disclosed herein is the continued optimization of our i.